Page last updated: 2024-11-01

omeprazole and Gastroenteritis

omeprazole has been researched along with Gastroenteritis in 12 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Gastroenteritis: INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.

Research Excerpts

ExcerptRelevanceReference
"A prolonged GA inhibitor-induced hypochlorhydria has been suggested as a risk factor for severe gastrointestinal infections."1.33Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. ( Canani, RB; Cirillo, P; Guarino, A; Malamisura, B; Manguso, F; Morelli, L; Passariello, A; Roggero, P; Romano, C; Terrin, G, 2006)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's7 (58.33)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wei, L1
Ratnayake, L1
Phillips, G1
McGuigan, CC1
Morant, SV1
Flynn, RW1
Mackenzie, IS1
MacDonald, TM1
Reimer, C1
Bytzer, P1
Wilton, LV1
Key, C1
Shakir, SA1
Pohland, CJ1
Scavnicky, SA1
Lasky, SS1
Good, CB1
Kornienko, EA1
Klochko, OG1
Tiesmeier, J1
Hinner, H1
Kraus, J1
Schuppert, F1
Canani, RB1
Cirillo, P1
Roggero, P1
Romano, C1
Malamisura, B1
Terrin, G1
Passariello, A1
Manguso, F1
Morelli, L1
Guarino, A1
García Rodríguez, LA1
Ruigómez, A1
Panés, J1
Neal, KR1
Scott, HM1
Slack, RC1
Logan, RF1
Tan, AC1
den Hartog, G1
Meijer, JW1
Thies, JE1
de Vries, RA1
Mulder, CJ1
Neal, K1
Logan, R1
Wingate, DL1

Trials

3 trials available for omeprazole and Gastroenteritis

ArticleYear
[Comparative efficacy of proton pump inhibitors in children].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2003, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles;

2003
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Bacterial Infections; Enzyme Inhibitors; Femal

2007
No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
    Helicobacter, 1997, Volume: 2, Issue:4

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Biopsy; Data Interpreta

1997

Other Studies

9 other studies available for omeprazole and Gastroenteritis

ArticleYear
Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; Cohort St

2017
[Adverse events associated with long-term use of proton pump inhibitors].
    Ugeskrift for laeger, 2012, Sep-24, Volume: 174, Issue:39

    Topics: Anti-Ulcer Agents; Bacterial Infections; Congenital Abnormalities; Dyspepsia; Fractures, Bone; Gastr

2012
The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England.
    Drug safety, 2003, Volume: 26, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen

2003
Lansoprazole overutilization: methods for step-down therapy.
    The American journal of managed care, 2003, Volume: 9, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Costs; Drug Utilization Review; Enz

2003
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
    Deutsche medizinische Wochenschrift (1946), 2004, Jul-09, Volume: 129, Issue:28-29

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U

2004
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Pediatrics, 2006, Volume: 117, Issue:5

    Topics: Achlorhydria; Acute Disease; Anti-Ulcer Agents; Child, Preschool; Community-Acquired Infections; Gas

2006
Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study.
    BMJ (Clinical research ed.), 1996, Feb-17, Volume: 312, Issue:7028

    Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter Infections; Case-Control Studies; Gast

1996
Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7

    Topics: Anti-Ulcer Agents; Campylobacter Infections; Gastric Acid; Gastroenteritis; Gastroesophageal Reflux;

2001
Acid reduction and recurrent enteritis.
    Lancet (London, England), 1990, Jan-27, Volume: 335, Issue:8683

    Topics: Adult; Gastroenteritis; Humans; Male; Omeprazole; Recurrence; Salmonella Infections

1990